Navigation Links
Cambridge Semantics to Highlight Innovations in Drug Safety and Business Development at DIA 2013
Date:6/13/2013

Boston, Ma (PRWEB) June 13, 2013

Cambridge Semantics will be a featured presenter at DIA 2013 taking place June 23rd through the 27th in Boston. As part of the Innovation Theater track, Cambridge Semantics will showcase how technology innovations made possible by semantics can help pharmaceutical companies improve drug safety and bolster business development while minimizing risk.

The most important data-related challenge facing pharma today is the ability to use data to make critical business decisions. Most of these decisions don’t need Big Data: they simply need the right data at the right time. Semantic Web standards enable pharmaceutical organizations to make data smarter by offering greater data access and data understanding, allowing them to more effectively mitigate risk across the drug development and commercialization spectrum.

Session information
Tuesday, June 25th at Noon EDT
Title: “How Can Technology Change the Way Pharmas Handle Risk? Innovations in Drug Safety and Business Development
Location: Exhibit Hall

Based on Semantic Web technologies, the award-winning Anzo Pharma Competitive Intelligence Solution from Cambridge Semantics is currently in use at some of the world’s top biopharma organizations. R&D teams, business development, marketing and knowledge management groups leverage Anzo to easily route targeted information to the right people at the right time from the right sources, incorporating both structured and unstructured data. As a result, pharmaceutical organizations can harmonize information more rapidly and make better business decisions.

To learn more about Cambridge Semantics and the award winning Anzo Pharma Competitive Intelligence Solution please visit http://www.cambridgesemantics.com.

About Cambridge Semantics
Cambridge Semantics provides the award-winning Anzo software suite, an open platform for building interactive Unified Information Access (UIA) solutions. Enterprises face an increasing need to rapidly discover, understand, combine, and act on data from diverse sources both from within and across organizational boundaries. Anzo makes it easy for both IT and end users to deal with this need by rapidly creating solutions that leverage unified access to structured and unstructured data from varied sources in the context of specific business problems.

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Twitter @CamSemantics.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10826188.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Inspiration Biopharmaceuticals Moves Corporate Headquarters to Cambridge, Massachusetts
2. Stevenage Bioscience Catalyst to Welcome Cambridge University Researchers
3. Cambridge Healthtech Associates™ Co-Sponsors BIO Debrief Networking Reception with Xconomy
4. H3 Biomedicine Expands Cambridge Facilities, Doubles Employee Base as Scientific Program Advances
5. P&P Optica Invited to Cambridge Innovation Centre for the Canadian Technology Accelerator Program, One of Eight Canadian Life Science Companies Chosen to Participate
6. Cambridge Semantics Named 2013 SIIA CODiE Award Finalist
7. Cambridge Semantics to Speak at 2013 Bio-IT World Conference & Expo
8. Cambridge College School of Management Program Hosts a Panel Discussion On Trends and Opportunities In Health Information Technology
9. Cambridge Semantics to Present the Case for Unified Information Access at Enterprise Data World 2013
10. Industry Leader Linguamatics Hosts Record-breaking Spring Users Conference in Cambridge, UK
11. Cambridge Semantics Wins SIIA Software CODiE Award for Best Business Intelligence and Analytics Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2017)... ... June 20, 2017 , ... National executive search firm, ... extensive assay development and biomarker expertise, as VP of Scientific Affairs at Cambridge ... in bio-analytical assay development and sample testing services. The organization acts as a ...
(Date:6/19/2017)... ... June 19, 2017 , ... Tunnell Consulting has been ... One of the biggest challenges faced by life sciences, biotech and pharmaceuticals companies today ... is Kati Abraham , who is well known in the industry and brings ...
(Date:6/15/2017)... ... 2017 , ... New resistant soybean and cotton cropping systems ... amaranth and other broadleaf weeds resistant to glyphosate. But scientists with the Weed ... known to drift and to cause harm to sensitive, off-target broadleaf plants. , ...
(Date:6/15/2017)... (PRWEB) , ... June 15, 2017 , ... ... published a new guide on how to assemble a lab workstation. The guide ... Workstation components include Adam’s Nimbus or Eclipse balance, AVT anti-vibration table, OIML/ASTM certified ...
Breaking Biology Technology:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
(Date:4/11/2017)... BEACH GARDENS, Fla. , April 11, 2017 ... identity management and secure authentication solutions, today announced ... contract by Intelligence Advanced Research Projects Activity (IARPA) ... for IARPA,s Thor program. "Innovation has ... onset and IARPA,s Thor program will allow us ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ... appointment of independent Directors Mr. Robin D. Richards ... Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive ... their guidance and benefiting from their considerable expertise as we ...
Breaking Biology News(10 mins):